The histone demethylase Utx controls CD8 + T‐cell‐dependent antitumor immunity via epigenetic regulation of the effector function
Cancer Science · 2023-07 · 114 (7) · 2787-2797
DOI: 10.1111/cas.15814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 17.04.2023. Verfasst von Haruna Noda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Breast Center, Ehime University Hospital, Toon, Japan. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Epigenesis, Genetic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
CD8 + T cells play a central role in antitumor immune responses. Epigenetic gene regulation is essential to acquire the effector function of CD8 + T cells. However, the role of Utx , a demethylase of histone H3K27, in antitumor immunity remains unclear. In this study, we examined the roles of Utx in effector CD8 + T‐cell differentiation and the antitumor immune response. In a murine tumor‐bearing model, an increased tumor size and decreased survival rate were observed in T‐cell‐specific Utx KO ( Utx KO) mice compared with wild‐type (WT) mice. The number of CD8 + T cells in tumor‐infiltrating lymphocytes (TILs) was significantly decreased in Utx KO mice. We found that the acquisition of effector function was delayed and attenuated in Utx KO CD8 + T cells. RNA sequencing revealed that the expression of effector signature genes was decreased in Utx KO effector CD8 + T cells, while the expression of naïve or memory signature genes was increased. Furthermore, the expression of Cxcr3, which is required for the migration of effector CD8 + T cells to tumor sites, was substantially decreased in Utx KO CD8 + T cells. These findings suggest that Utx promotes CD8 + T‐cell‐dependent antitumor immune responses partially through epigenetic regulation of the effector function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Breast Center, Ehime University Hospital, Toon, Japan.
- Department of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Graduate School of Medicine, Ehime University, Toon, Japan.
- Department of Immunology, Graduate School of Medicine, Ehime University, Toon, Japan.
- Department of Translational Research Center, Ehime University Hospital, Toon, Japan.
- Department of Infections and Host Defenses, Graduate School of Medicine, Ehime University, Toon, Japan.
ORCID-Profile: Masakatsu Yamashita
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Noda, H., Suzuki, J., Matsuoka, Y., Matsumoto, A., Kuwahara, M., Kamei, Y., Takada, Y., & Yamashita, M. (2023). The histone demethylase Utx controls CD8 + T‐cell‐dependent antitumor immunity via epigenetic regulation of the effector function. Cancer Science, 114(7), 2787-2797. https://doi.org/10.1111/cas.15814
Vancouver
Noda H, Suzuki J, Matsuoka Y, Matsumoto A, Kuwahara M, Kamei Y, et al. The histone demethylase Utx controls CD8 + T‐cell‐dependent antitumor immunity via epigenetic regulation of the effector function. Cancer Science. 2023;114(7):2787-2797. doi:10.1111/cas.15814
BibTeX
@article{Noda2023,
author = {Noda, Haruna and Suzuki, Junpei and Matsuoka, Yuko and Matsumoto, Akira and Kuwahara, Makoto and Kamei, Yoshiaki and Takada, Yasutsugu and Yamashita, Masakatsu},
title = {The histone demethylase Utx controls CD8 + T‐cell‐dependent antitumor immunity via epigenetic regulation of the effector function},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {7},
pages = {2787--2797},
doi = {10.1111/cas.15814}
}
EUVIMED